Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Impact and Time Course of Colchicine Therapy on C-reactive Protein Elevation in Chronic Atrial Fibrillation (AF) and Post AF Ablation

Trial Profile

Impact and Time Course of Colchicine Therapy on C-reactive Protein Elevation in Chronic Atrial Fibrillation (AF) and Post AF Ablation

Completed
Phase of Trial: Phase II

Latest Information Update: 10 May 2019

At a glance

  • Drugs Colchicine (Primary)
  • Indications Atrial fibrillation
  • Focus Pharmacodynamics
  • Most Recent Events

    • 18 Apr 2019 Status changed from recruiting to completed.
    • 31 Aug 2018 Biomarkers information updated
    • 24 Mar 2015 Planned End Date changed from 1 Jun 2015 to 1 Jun 2016, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top